Effect of the CRTH2 Antagonist OC459 on the Response to Rhinovirus Challenge in Asthma
Phase of Trial: Phase II
Latest Information Update: 13 Jul 2017
At a glance
- Drugs OC 459 (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms ORCA
- 13 Jul 2017 Planned number of patients changed from 34 to 44.
- 10 Jun 2017 Biomarkers information updated
- 24 Dec 2016 Planned number of patients changed to 34.